Logo image of HHRS

HAMMERHEAD ENERGY INC (HHRS) Stock Fundamental Analysis

NASDAQ:HHRS - Nasdaq - CA4083021077 - Common Stock - Currency: USD

15.32  -0.02 (-0.13%)

Fundamental Rating

1

HHRS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 208 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of HHRS have multiple concerns. HHRS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HHRS has reported negative net income.
HHRS Yearly Net Income VS EBIT VS OCF VS FCFHHRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of HHRS (-6.55%) is worse than 88.99% of its industry peers.
HHRS has a worse Return On Equity (-9.49%) than 84.40% of its industry peers.
HHRS's Return On Invested Capital of 4.27% is on the low side compared to the rest of the industry. HHRS is outperformed by 74.77% of its industry peers.
Industry RankSector Rank
ROA -6.55%
ROE -9.49%
ROIC 4.27%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HHRS Yearly ROA, ROE, ROICHHRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 -0.5 -1 -1.5

1.3 Margins

HHRS has a Operating Margin (27.99%) which is comparable to the rest of the industry.
HHRS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 27.99%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HHRS Yearly Profit, Operating, Gross MarginsHHRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for HHRS has been increased compared to 1 year ago.
The debt/assets ratio for HHRS is higher compared to a year ago.
HHRS Yearly Shares OutstandingHHRS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 20M 40M 60M 80M
HHRS Yearly Total Debt VS Total AssetsHHRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 500M 1B 1.5B

2.2 Solvency

HHRS has an Altman-Z score of 3.04. This indicates that HHRS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.04, HHRS is in the better half of the industry, outperforming 74.77% of the companies in the same industry.
A Debt/Equity ratio of 0.27 indicates that HHRS is not too dependend on debt financing.
The Debt to Equity ratio of HHRS (0.27) is better than 65.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 3.04
ROIC/WACCN/A
WACCN/A
HHRS Yearly LT Debt VS Equity VS FCFHHRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.91 indicates that HHRS may have some problems paying its short term obligations.
HHRS has a worse Current ratio (0.91) than 66.97% of its industry peers.
HHRS has a Quick Ratio of 0.91. This is a bad value and indicates that HHRS is not financially healthy enough and could expect problems in meeting its short term obligations.
HHRS has a Quick ratio (0.91) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
HHRS Yearly Current Assets VS Current LiabilitesHHRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 50M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for HHRS have decreased strongly by -100.00% in the last year.
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-79.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-29.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HHRS Yearly Revenue VS EstimatesHHRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 200M 400M 600M 800M
HHRS Yearly EPS VS EstimatesHHRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HHRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 9.09 indicates a reasonable valuation of HHRS.
HHRS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HHRS is cheaper than 60.09% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.78. HHRS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 9.09
HHRS Price Earnings VS Forward Price EarningsHHRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HHRS Per share dataHHRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HHRS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HAMMERHEAD ENERGY INC

NASDAQ:HHRS (12/20/2023, 8:15:51 PM)

15.32

-0.02 (-0.13%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-06 2023-11-06/amc
Earnings (Next)N/A N/A
Inst Owners0.07%
Inst Owner Change-83.46%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.47B
Analysts80
Price Target15.96 (4.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-289.84%
Min EPS beat(2)-534.29%
Max EPS beat(2)-45.4%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-16.7%
Min Revenue beat(2)-19.43%
Max Revenue beat(2)-13.96%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.97%
PT rev (3m)15.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.85%
EPS NY rev (1m)-100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)5.73%
Revenue NY rev (3m)5.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.09
P/S 5.61
P/FCF N/A
P/OCF N/A
P/B 1.48
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)1.69
Fwd EY11%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.73
BVpS10.37
TBVpS10.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.55%
ROE -9.49%
ROCE 5.4%
ROIC 4.27%
ROICexc 4.28%
ROICexgc 4.28%
OM 27.99%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z 3.04
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-79.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-29.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y100%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100%
OCF growth 3YN/A
OCF growth 5YN/A